Terms: = Pancreatic cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
224 results:
1. Development, synthesis and validation of improved c-Myc/max inhibitors.
Yıldırım S; Kocabaş F; Mermer A
J Cell Mol Med; 2024 Apr; 28(8):e18272. PubMed ID: 38568057
[TBL] [Abstract] [Full Text] [Related]
2. EUS-guided tissue acquisition in patients with solid pseudopapillary neoplasms of the pancreas.
Jiménez-Gutiérrez JM; de la Mora-Levy JG; Alonso-Lárraga JO; Hernández-Guerrero AI; Soriano-Herrera BA; Villegas-González LF; Uscanga-Domínguez LF; López-Romero S; Téllez-Ávila FI
Postgrad Med; 2024 Jan; 136(1):78-83. PubMed ID: 38315145
[TBL] [Abstract] [Full Text] [Related]
3. Potential Added Value of
Chen S; Wang G; Wu L; Chen D; Fang K; Liu W; Xu B; Zhai YQ; Li M
BMC Gastroenterol; 2024 Jan; 24(1):37. PubMed ID: 38233765
[TBL] [Abstract] [Full Text] [Related]
4. The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy.
Yang Y; Li L; Xu Y; Ouyang J; Zhou Y; Ye F; Huang Z; Zhang W; Zhou A; Zhao X; Cai J; Wang Y; Zhou J; Zhao H
Radiol Med; 2024 Feb; 129(2):188-201. PubMed ID: 38180570
[TBL] [Abstract] [Full Text] [Related]
5.
Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract] [Full Text] [Related]
7. Prediction of
Mileva M; Marin G; Levillain H; Artigas C; Van Bogaert C; Marin C; Danieli R; Deleporte A; Picchia S; Stathopoulos K; Jungels C; Vanderlinden B; Paesmans M; Ameye L; Critchi G; Taraji-Schiltz L; Velghe C; Wimana Z; Bali M; Hendlisz A; Flamen P; Karfis I
J Nucl Med; 2024 Feb; 65(2):236-244. PubMed ID: 38164576
[TBL] [Abstract] [Full Text] [Related]
8. Air quality and cancer risk in the All of Us Research Program.
Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
[TBL] [Abstract] [Full Text] [Related]
9. Mechanisms Behind the Pharmacological Application of Biochanin-A: A review.
Anuranjana PV; Beegum F; K P D; George KT; Viswanatha GL; Nayak PG; Kanwal A; Kishore A; Shenoy RR; Nandakumar K
F1000Res; 2023; 12():107. PubMed ID: 38106650
[TBL] [Abstract] [Full Text] [Related]
10. Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
Seckinger A; Majocchi S; Moine V; Nouveau L; Ngoc H; Daubeuf B; Ravn U; Pleche N; Calloud S; Broyer L; Cons L; Lesnier A; Chatel L; Papaioannou A; Salgado-Pires S; Krämer S; Gockel I; Lordick F; Masternak K; Poitevin Y; Magistrelli G; Malinge P; Shang L; Kallendrusch S; Strein K; Hose D
J Hematol Oncol; 2023 Dec; 16(1):117. PubMed ID: 38087365
[TBL] [Abstract] [Full Text] [Related]
11.
Kessler L; Hirmas N; Pabst KM; Hamacher R; Ferdinandus J; Schaarschmidt BM; Milosevic A; Nader M; Umutlu L; Uhl W; Reinacher-Schick A; Lugnier C; Witte D; Niedergethmann M; Herrmann K; Fendler WP; Siveke JT
J Nucl Med; 2023 Dec; 64(12):1910-1917. PubMed ID: 37973185
[TBL] [Abstract] [Full Text] [Related]
12. Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with
Watabe T; Kabayama K; Naka S; Yamamoto R; Kaneda K; Serada S; Ooe K; Toyoshima A; Wang Y; Haba H; Kurimoto K; Kobayashi T; Shimosegawa E; Tomiyama N; Fukase K; Naka T
J Nucl Med; 2023 Dec; 64(12):1949-1955. PubMed ID: 37827841
[TBL] [Abstract] [Full Text] [Related]
13. Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer.
Khojasteh-Leylakoohi F; Mohit R; Khalili-Tanha N; Asadnia A; Naderi H; Pourali G; Yousefli Z; Khalili-Tanha G; Khazaei M; Maftooh M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Shahidsales S; Lam AK; Giovannetti E; Nazari E; Batra J; Avan A
Sci Rep; 2023 Oct; 13(1):16678. PubMed ID: 37794108
[TBL] [Abstract] [Full Text] [Related]
14.
Ma XK; Liu TL; Ren YN; Ma XP; Yao Y; Hou XG; Ding J; Wang F; Huang HF; Zhu H; Yang Z
Acta Pharmacol Sin; 2024 Feb; 45(2):436-448. PubMed ID: 37749238
[TBL] [Abstract] [Full Text] [Related]
15. Clinical application of Al
Lyu Z; Han W; Zhang Q; Zhao H; Liu S; Wang Y; He J; Zhao C; Tian L; Fu P
Cancer Imaging; 2023 Sep; 23(1):86. PubMed ID: 37700343
[TBL] [Abstract] [Full Text] [Related]
16. Feasibility of acquisitions using total-body PET/CT with a half-dose [
Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
[TBL] [Abstract] [Full Text] [Related]
17. Tumor Characterization by [
Rasinski P; Af Burén S; Holstensson M; Nilsson T; Loizou L; Tran TA; Sparrelid E; Löhr JM; Axelsson R
J Nucl Med; 2023 Aug; 64(8):1232-1237. PubMed ID: 37348917
[TBL] [Abstract] [Full Text] [Related]
18. [
Zhu Z; Cheng K; Yun Z; Zhang X; Hu X; Liu J; Wang F; Fu Z; Yue J
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3425-3438. PubMed ID: 37328622
[TBL] [Abstract] [Full Text] [Related]
19. Relationship between the expression of PD-L1 and
Li J; Chen R; Chen Y; Xia Q; Zhou X; Xia Q; Wang C; Wan L; Bao H; Huang G; Liu J
Br J Cancer; 2023 Aug; 129(3):541-550. PubMed ID: 37311977
[TBL] [Abstract] [Full Text] [Related]
20. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
[Next]
